The Leading AI-Powered Search for Life Sciences
Discover your next breakthrough
Over ½ of the world’s top Life Sciences organizations use Sinequa to find information across Clinical Trials, Drug Development, Regulatory, and more.
ChapsVision Strengthens AI Capabilities with Sinequa Acquisition and Completes New US$90M Funding Round. Learn more
Sinequa GenAI Assistant
The Leading AI-Powered Search for Life Sciences
Over ½ of the world’s top Life Sciences organizations use Sinequa to find information across Clinical Trials, Drug Development, Regulatory, and more.
Are you missing critical information about a disease, target, or compound of interest? With scientific content available from an ever-increasing number of data sources, it’s difficult to know where to start. Any researchers needing to perform an in-depth analysis of the huge volume data at their disposal would need to prepare multiple detailed searches across many different sources to ensure they don’t miss something important. This is what Sinequa’s Search Cloud platform combined with GenAI delivers.
Sinequa connects any content source so researchers have the data to make better, faster decisions about compounds, diseases, drug targets, and more.
Learn more
Sinequa Search puts crucial data points, protocols, variables, and more in one place so biostatisticians can find what they need to execute complicated analysis requests up to 20% faster and improve clinical outcomes.
Learn more0%
faster biostatistician data inquiries
0%
faster time-to-market for therapies
$0M
saved with Phase 1/2 pass/fail ratio improvements
Sinequa’s AI-powered search allows scientists, biostatisticians, product owners, and regulatory affairs to discover critical knowledge and expertise across the drug development process – right when they need it.
Sinequa is simply great technology. We immediately saw its benefit watching it perform something we didn’t know was possible. It makes an exponential difference for our organization. We were also impressed with the number of smart connectors available out-of-the-box and Sinequa’s unique ability to develop new ones.
Oliver Thoennessen, Senior Manager Global IT Drug Development, UCB
Deliver safe, effective, and viable therapies to market faster
Quickly identify TPPs and candidates, make more informed trial decisions, and reduce compliance risk
Home in on the right datasets quickly to execute complicated studies and analysis requests.
Get relevant insights to employees to minimize mistakes, delays, and duplication.
